MedTrace Logo

Long-term Follow-up of Anterior Cruciate Ligament Injury

NCT03182647 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-07-02

No results posted yet for this study

Summary

Anterior cruciate ligament (ACL) rupture is one of the most common sports-related knee injuries. Because it is such a significant injury - requiring a long period of rehabilitation before the injured person is ready to return to physical activity, the burden of injury is high. This can help to explain why so much of orthopaedic research is devoted to evaluating the outcomes of ACL injury. However, while there has been extensive study of short-term (up to 5 years after injury) outcomes, few studies have followed patients beyond 15 years after their ACL injury. This is important because long-term follow-up can provide key insights to guide the information provided to newly injured patients (e.g. to help set realistic expectations of what the injured person can expect of their knee function in the future), and help us evaluate the efficacy of previous treatments.

The primary aim is to assess the influence of an acute ACL injury on knee function and quality of life, 32-37 years after the index injury. Approximately 300 patients injured between 1980 and 1985 will be invited to participate in the study. Patient- and clinician-reported outcomes, and radiographic osteoarthritis will be evaluated.

Conditions

  • Anterior Cruciate Ligament Injury

Interventions

PROCEDURE

Surgically treatment of the ACL

Surgical initial ACL treatment

OTHER

Non surgical initial ACL treatment

Non surgical initial ACL treatment

Sponsors & Collaborators

  • Linkoeping University

    lead OTHER_GOV

Principal Investigators

  • Joanna Kvist, Professor · IMH Linkoping University, Sweden

Eligibility

Min Age
47 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-09
Primary Completion
2017-12-31
Completion
2018-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182647 on ClinicalTrials.gov